Instil Bio, Inc. Increase (Decrease) in Accounts Payable
Instil Bio, Inc. (TIL) reported Increase (Decrease) in Accounts Payable of $17.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- Instil Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $17.00K.
- Instil Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$148.00K.
- Instil Bio, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $403.00K.
- Instil Bio, Inc. increase (decrease) in accounts payable for fiscal 2025 was $116.00K.
- Instil Bio, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$556.00K.
- Instil Bio, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$1.13M.
- Instil Bio, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.81M, a 146.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $17.00K 10-Q · filed 2026-08-13 | -$131.00K derived: sum of 3 quarters · filed 2026-08-13 | $272.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-15 | -$131.00K derived: sum of 2 quarters · filed 2026-05-15 | $272.00K derived: sum of 3 quarters · filed 2026-05-15 | $509.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $255.00K derived: sum of 2 quarters · filed 2026-03-27 | $492.00K derived: sum of 3 quarters · filed 2026-08-13 | $116.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $640.00K derived: sum of 2 quarters · filed 2026-08-13 | $264.00K 10-Q · filed 2025-11-13 | -$258.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$139.00K 10-Q · filed 2026-08-13 | -$661.00K derived: sum of 3 quarters · filed 2026-08-13 | -$706.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$376.00K 10-Q · filed 2026-05-15 | -$898.00K derived: sum of 2 quarters · filed 2026-05-15 | -$943.00K derived: sum of 3 quarters · filed 2026-05-15 | -$952.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$567.00K derived: sum of 2 quarters · filed 2026-03-27 | -$576.00K derived: sum of 3 quarters · filed 2026-03-27 | -$556.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$54.00K derived: sum of 2 quarters · filed 2025-11-13 | -$34.00K 10-Q · filed 2025-11-13 | -$511.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $11.00K 10-Q · filed 2025-08-13 | -$466.00K derived: sum of 3 quarters · filed 2025-08-13 | -$891.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-13 | -$457.00K derived: sum of 2 quarters · filed 2025-05-13 | -$882.00K derived: sum of 3 quarters · filed 2025-05-13 | -$129.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$902.00K derived: sum of 2 quarters · filed 2025-03-04 | -$149.00K derived: sum of 3 quarters · filed 2025-03-04 | -$1.13M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $328.00K derived: sum of 2 quarters · filed 2024-11-13 | -$652.00K 10-Q · filed 2024-11-13 | -$3.14M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$227.00K 10-Q · filed 2024-08-13 | -$2.72M derived: sum of 3 quarters · filed 2024-08-13 | -$2.95M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$980.00K 10-Q · filed 2024-05-10 | -$3.47M derived: sum of 2 quarters · filed 2024-05-10 | -$3.70M derived: sum of 3 quarters · filed 2024-05-10 | $413.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.72M derived: sum of 2 quarters · filed 2024-03-21 | $1.39M derived: sum of 3 quarters · filed 2024-03-21 | -$1.81M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.88M derived: sum of 2 quarters · filed 2023-11-13 | $683.00K 10-Q · filed 2023-11-13 | $795.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $915.00K 10-Q · filed 2023-08-14 | $1.03M derived: sum of 3 quarters · filed 2023-08-14 | $2.78M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$3.20M 10-Q · filed 2023-05-11 | -$3.09M derived: sum of 2 quarters · filed 2023-05-11 | -$1.33M derived: sum of 3 quarters · filed 2023-05-11 | $934.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.87M derived: sum of 2 quarters · filed 2023-03-31 | $4.13M derived: sum of 3 quarters · filed 2023-03-31 | $3.86M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.02M derived: sum of 2 quarters · filed 2022-11-14 | $3.75M 10-Q · filed 2022-11-14 | $3.27M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.00M 10-Q · filed 2022-08-12 | $1.51M derived: sum of 3 quarters · filed 2022-08-12 | $1.83M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$271.00K 10-Q · filed 2022-05-16 | -$756.00K derived: sum of 2 quarters · filed 2022-05-16 | -$439.00K derived: sum of 3 quarters · filed 2022-05-16 | -$727.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$168.00K derived: sum of 2 quarters · filed 2022-03-07 | -$456.00K derived: sum of 3 quarters · filed 2022-03-07 | -$1.05M 10-K · filed 2022-03-07 |
| 2020-09-30 | $317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $29.00K derived: sum of 2 quarters · filed 2021-11-15 | -$569.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$886.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$598.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |